Jayaprakasam Madhumathi Selected Research

difluprednate

6/2011	Proliferative responses of Brugia malayi TPX-1 and its epitopic peptide(29-43) in an endemic population of human lymphatic filariasis.
7/2010	Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jayaprakasam Madhumathi Research Topics

Disease

5	Filarial Elephantiasis (Lymphatic Filariasis) 11/2018 - 07/2010
3	Infections 06/2014 - 09/2011
3	Filariasis 06/2011 - 07/2010
2	Hematologic Neoplasms (Hematological Malignancy) 02/2016 - 01/2016
1	COVID-19 11/2021
1	Leukemia 01/2016
1	Neoplasms (Cancer) 01/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 12/2013 - 07/2010
3	EpitopesIBA 06/2011 - 07/2010
2	Immunotoxins (Immunotoxin)IBA 02/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2010
2	AntigensIBA 12/2013 - 09/2011
2	difluprednate FDA Link 06/2011 - 07/2010
2	Peptides (Polypeptides)IBA 12/2010 - 07/2010
1	Air Pollutants (Pollutants, Air)IBA 11/2021
1	antiarrhythmic peptide (AAP)IBA 11/2021
1	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2018
1	LigandsIBA 01/2016
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2016
1	DNA VaccinesIBA 06/2014
1	AllergensIBA 12/2013
1	ThioredoxinsIBA 12/2013
1	VenomsIBA 12/2013
1	Monoclonal AntibodiesIBA 09/2011
1	PeroxiredoxinsIBA 06/2011
1	AntioxidantsIBA 06/2011
1	Immune Sera (Antisera)IBA 12/2010
1	Synthetic Vaccines (Recombinant Vaccines)IBA 07/2010

Therapy/Procedure

2	Therapeutics 02/2016 - 01/2016